Baird Medical Investment Holdings Limited (BDMD)

CN — Healthcare Sector
Peers:

Automate Your Wheel Strategy on BDMD

With Tiblio's Option Bot, you can configure your own wheel strategy including BDMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol BDMD
  • Rev/Share 1.7583
  • Book/Share 5.254
  • PB 0.8147
  • Debt/Equity 0.3953
  • CurrentRatio 2.0974
  • ROIC 0.0647

 

  • MktCap 152918519.0
  • FreeCF/Share -0.6492
  • PFCF -31.5263
  • PE 8.8195
  • Debt/Assets 0.2463
  • DivYield 0
  • ROE 0.1199

 

  • Rating B+
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 5
  • P/B Score 3
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Baird Medical Engages Global Clinical Leaders at AAES 2025
BDMD
Published: May 19, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , May 19, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place from May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.

Read More
image for news Baird Medical Engages Global Clinical Leaders at AAES 2025
Baird Medical Advances Thyroid MWA Training and Academic Exchange with Leading Harvard Professor
BDMD
Published: May 12, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , May 12, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in Microwave Ablation (MWA) technology, recently hosted an advanced training session and academic exchange in New Orleans, reinforcing its commitment to clinical innovation and research collaboration in minimally invasive thyroid therapies.

Read More
image for news Baird Medical Advances Thyroid MWA Training and Academic Exchange with Leading Harvard Professor
Baird Medical to Participate in the AAES 2025 Annual Meeting
BDMD
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , May 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.

Read More
image for news Baird Medical to Participate in the AAES 2025 Annual Meeting

About Baird Medical Investment Holdings Limited (BDMD)

  • IPO Date 2021-12-16
  • Website https://www.bairdmed.com
  • Industry Medical - Devices
  • CEO Ms. Haimei Wu
  • Employees 148
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.